Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|January 14, 1982
[Retroperitoneal malignant xanthogranuloma (author's transl)]M Briffod, J Berlie, B Clavel, et al.
Cancer Research|May 30, 1998
Location of several putative genes possibly involved in human breast cancer progressionK Driouch, M Briffod, I Bièche, et al.
Presse Medicale (Paris, France : 1983)|June 15, 1991
[Optimal sampling for diagnostic and prognostic purposes before first-line chemotherapy of breast cancer]M Tubiana-Hulin, M Briffod, F Spyratos, et al.
Analytical and Quantitative Cytology and Histology|December 1, 1987
Flow cytometric study of DNA distribution in cytopunctures of benign and malignant breast lesionsF Spyratos, M Briffod, A Gentile, et al.
Genes, Chromosomes & Cancer|July 1, 1997
Loss of heterozygosity on chromosome arm 16q in breast cancer metastasesK Driouch, F Dorion-Bonnet, M Briffod, et al.
The International Journal of Biological Markers|September 30, 2000
CCND1 mRNA overexpression is highly related to estrogen receptor positivity but not to proliferative markers in primary breast cancerF Spyratos, C Andrieu, D Vidaud, et al.
Cancer|February 15, 1989
Sequential cytopunctures during preoperative chemotherapy for primary breast carcinoma. Cytomorphologic changes, initial tumor ploidy, and tumor regressionM Briffod, F Spyratos, M Tubiana-Hulin, et al.
Cytometry|January 1, 1992
Evaluation of breast carcinoma chemosensitivity by flow cytometric DNA analysis and computer assisted image analysisM Briffod, F Spyratos, K Hacène, et al.
Annales De Pathologie|August 12, 2003
[2002 Standards, Options and Recommendations: good practice for the management and shipment of histological and cytopathological cancer specimens]Y Denoux, M P Blanc-Vincent, J Simony-Lafontaine, et al.
Cancer|January 15, 1992
Sequential cytopunctures during preoperative chemotherapy for primary breast carcinoma. II. DNA flow cytometry changes during chemotherapy, tumor regression, and short-term follow-upF Spyratos, M Briffod, M Tubiana-Hulin, et al.
Pageof 3